miRNA | Experimental models | Major findings | Targets | Ref. |
---|---|---|---|---|
miR-590-3p | neonatal rat CMs, neonatal mouse CMs, postnatal rat (P7) CMs | Overexpression of miR-590-3p increases CM proliferation. | Homer1, Hopx, Hippo pathway | |
delivery of hsa-miR-590-3p complexed with a lipid transfection reagent into the heart of neonatal rats | The left ventricle walls of the hearts appeared markedly thicker with increases CM proliferation. | |||
delivery of AAV9-miR590 precursor miRNAs into the neonatal mice | At 12 days after injection, the hearts were morphologically normal, but significantly enlarged. | |||
delivery of AAV9-miR590 into the adult mice after infarction | The infarct size was significantly reduced in mice. | |||
miR-199a-3p | neonatal rat CMs, neonatal mouse CMs, postnatal rat (P7) CMs | Overexpression of miR-199a-3p increases CM proliferation. | Homer1, Clic5, Cd151, Hippo pathway | (Eulalio et al. 2012; Lesizza et al. 2017; Gabisonia et al. 2019; Tao et al. 2019; Torrini et al. 2019) |
delivery of hsa-miR-199a-3p complexed with a lipid transfection reagent into the heart of neonatal rats | The left ventricle walls of the hearts appeared markedly thicker with increases CM proliferation. | |||
delivery of AAV9-miR-199a-3p precursor miRNAs into the neonatal mice | At 12 days after injection, the hearts of these animals were morphologically normal, but significantly enlarged. | |||
delivery of AAV9-miR-199a-3p into the adult mice after infarction | The infarct size was significantly reduced in mice. | |||
delivery of AAV9-miR 199a-1 pri-miRNA into the infarcted pig hearts | The treated animals showed marked improvements in both global and regional contractility, increased muscle mass and reduced scar size. At longer follow-up, however, persistent and uncontrolled expression of the microRNA resulted in sudden arrhythmic death of most of the treated pigs. | |||
miR-17-92 Cluster | miR-17-92-cKO mice | miR-17-92 is sufficient to induce cardiomyocyte proliferation in embryonic and postnatal hearts. | Pten | (Chen et al. 2013) |
cardiac-specific overexpression miR-17-92 transgenic mice | Overexpression of miR-17-92 induces cardiomyocyte proliferation in embryonic, neonatal and adult hearts. Overexpression of miR-17-92 in adult cardiomyocytes protects the heart from myocardial infarction-induced injury. | |||
neonatal rat CMs | miR-17-92 is sufficient to induce neonatal cardiomyocyte proliferation. | |||
direct injection of miR-19a/19b mimics into the heart of a mouse model of MI | miR-19a/19b overexpression enhances cardiomyocyte proliferation and stimulates cardiac regeneration in response to myocardial infarction (MI) injury. | |||
miRNA-204 | neonatal and adult rat CMs | Overexpression of miRNA-204 promotes cardiomyocyte proliferation | Jarid2 | (Liang et al. 2015) |
cardiac-specific overexpression miRNA-204 transgenic mice | Overexpression of miRNA-204 promotes cardiomyocyte proliferation throughout the embryonic and adult stages. | |||
miR302–367 cluster | cardiac-specific overexpression miR302–367 transgenic mice | Overexpression of miR302–367 promotes cardiomyocyte proliferation in embryonic and postnatal hearts, and miR302–367 promotes adult cardiac regeneration after myocardial infarction. | Hippo pathway | (Tian et al. 2015) |
delivery miR302–367 mimics into the adult mice | Overexpression of miR302–367 promotes cardiac regeneration and improves function after injury. | |||
miR-210 | neonatal rat CMs | miR-210 induces proliferation. | Apc | (Arif et al. 2017) |
miR-210 overexpressing transgenic (210-TG) mice | miR-210 overexpression promotes CM proliferation in adult mice post-ischemic injury. | |||
miR-708 | H9C2 cells, neonatal rat CMs, neonatal mouse CMs | Overexpression of miR-708 promotes myocardium regeneration and heart function recovery. | Mapk14 | (Deng et al. 2017) |
delivery miR-708 mimics to a mice model of cardiac hypertrophy | ||||
miR-1825 | adult CMs | Overexpression of miR-1825 induces robust proliferation. | Hippo pathway | (Pandey et al. 2017) |
direct injection of AAV-miR-1825 into mice | Overexpression of miR-1825 improves heart function. | |||
miR-31a-5p | neonatal rat CMs | Overexpression of miR-31a-5p promotes cardiomyocyte proliferation. | Rhobtb1 | (Xiao et al. 2017) |
neonatal rats were injected intraperitoneally with the miR-31a-5p antagomir | Inhibition of miR-31a-5p decreases cardiomyocyte proliferation. | |||
miR-294 | neonatal and adult rat CMs | Overexpression of miR-294 promotes cell cycle activity. | Wee1 | (Borden et al. 2019) |
delivery of AAV-9-miR-294 to mice after MI | Overexpression of miR-294 promotes cell cycle reentry and improves cardiac function. | |||
miR-152 | neonatal CMs | Overexpression of miR-152 promotes neonatal cardiomyocyte proliferation. | Cdkn1b and Dnmt1 | (Wang et al. 2018) |
miR-25 | neonatal and adult CMs | Inhibition of miR-25 reduces neonatal and adult cardiomyocyte proliferation. | Bim and FBXW7 | |
hESC-CM | miR-25 promotes hESC-CM proliferation. | |||
Transgenic zebrafish | Overexpressing miR-25 promotes cardiomyocyte proliferation in zebrafish. |